Infection-Induced SARS-CoV-2 Seroprevalence among Blood Donors, Japan, 2022
Emerging Infectious Diseases · 2023-09 · 29 (9)
DOI: 10.3201/eid2909.230365 ↗Kurz gefasst
Fachartikel in der Zeitschrift Emerging Infectious Diseases, 2023-09. Verfasst von Ryo Kinoshita und 7 weiteren Autor:innen. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Zitieren
APA
Kinoshita, R., Arashiro, T., Kitamura, N., Arai, S., Takahashi, K., Suzuki, T., Suzuki, M., & Yoneoka, D. (2023). Infection-Induced SARS-CoV-2 Seroprevalence among Blood Donors, Japan, 2022. Emerging Infectious Diseases, 29(9). https://doi.org/10.3201/eid2909.230365
Vancouver
Kinoshita R, Arashiro T, Kitamura N, Arai S, Takahashi K, Suzuki T, et al. Infection-Induced SARS-CoV-2 Seroprevalence among Blood Donors, Japan, 2022. Emerging Infectious Diseases. 2023;29(9). doi:10.3201/eid2909.230365
BibTeX
@article{Kinoshita2023,
author = {Kinoshita, Ryo and Arashiro, Takeshi and Kitamura, Noriko and Arai, Satoru and Takahashi, Koki and Suzuki, Tadaki and Suzuki, Motoi and Yoneoka, Daisuke},
title = {Infection-Induced SARS-CoV-2 Seroprevalence among Blood Donors, Japan, 2022},
journal = {Emerging Infectious Diseases},
year = {2023},
volume = {29},
number = {9},
doi = {10.3201/eid2909.230365}
}
EUVIMED